Maybe it's actually a good thing we didn't get eua for mild to moderate. The drugs that were aren't being used much. I wonder if it's a cost to benefit issue? Seems like they might only be used if really necessary. Also, the fact that it's an IV at a time when hospital's are getting pushed to capacity so those IV patients with mild to moderate cv-19 may have to get better on their own time. I doubt a subcutaneous injection that keeps people from dying and speeds up time to discharge will be underutilized. Should be a very welcome breath of fresh air.
IMO. the previous contains forward looking statements, may be materially different from actual events, yada, yada, yada.
Link to my source below